Overview

Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
Determine long-term safety and tolerability of pregabalin in patients with anxiety disorders.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin